Bristol Myers Squibb Stock Price Prediction

BMY Stock  USD 58.87  0.64  1.10%   
The relative strength index (RSI) of Bristol Myers' share price is above 70 at this time suggesting that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Bristol, making its price go up or down.

Oversold Vs Overbought

71

 
Oversold
 
Overbought
The successful prediction of Bristol Myers' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Bristol Myers Squibb, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Bristol Myers' stock price prediction:
Quarterly Earnings Growth
(0.36)
EPS Estimate Next Quarter
1.52
EPS Estimate Current Year
0.902
EPS Estimate Next Year
7.0601
Wall Street Target Price
59.3691
Using Bristol Myers hype-based prediction, you can estimate the value of Bristol Myers Squibb from the perspective of Bristol Myers response to recently generated media hype and the effects of current headlines on its competitors.

Bristol Myers Squibb Hype to Price Pattern

Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Bristol Myers' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Bristol Myers.
The fear of missing out, i.e., FOMO, can cause potential investors in Bristol Myers to buy its stock at a price that has no basis in reality. In that case, they are not buying Bristol because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bristol Myers after-hype prediction price

    
  USD 59.46  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Bristol Myers Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
52.9869.1071.08
Details
Naive
Forecast
LowNextHigh
55.8157.8059.78
Details
27 Analysts
Consensus
LowTargetHigh
65.1371.5779.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.160.230.27
Details

Bristol Myers After-Hype Price Prediction Density Analysis

As far as predicting the price of Bristol Myers at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bristol Myers or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bristol Myers, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bristol Myers Estimiated After-Hype Price Volatility

In the context of predicting Bristol Myers' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bristol Myers' historical news coverage. Bristol Myers' after-hype downside and upside margins for the prediction period are 57.48 and 61.44, respectively. We have considered Bristol Myers' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
58.87
59.46
After-hype Price
61.44
Upside
Bristol Myers is very steady at this time. Analysis and calculation of next after-hype price of Bristol Myers Squibb is based on 3 months time horizon.

Bristol Myers Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Bristol Myers is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bristol Myers backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bristol Myers, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.35 
2.00
  0.61 
  0.02 
7 Events / Month
7 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
58.87
59.46
1.00 
115.61  
Notes

Bristol Myers Hype Timeline

On the 25th of November Bristol Myers Squibb is traded for 58.87. The entity has historical hype elasticity of 0.61, and average elasticity to hype of competition of -0.02. Bristol is expected to increase in value after the next headline, with the price projected to jump to 59.46 or above. The average volatility of media hype impact on the company the price is about 115.61%. The price jump on the next news is projected to be 1.0%, whereas the daily expected return is currently at 0.35%. The volatility of related hype on Bristol Myers is about 3600.0%, with the expected price after the next announcement by competition of 58.85. The company reported the last year's revenue of 45.01 B. Total Income to common stockholders was 8.04 B with profit before taxes, overhead, and interest of 36.38 B. Considering the 90-day investment horizon the next expected press release will be in about 7 days.
Check out Bristol Myers Basic Forecasting Models to cross-verify your projections.

Bristol Myers Related Hype Analysis

Having access to credible news sources related to Bristol Myers' direct competition is more important than ever and may enhance your ability to predict Bristol Myers' future price movements. Getting to know how Bristol Myers' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bristol Myers may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CAPRCapricor Therapeutics(0.08)11 per month 4.10  0.23  18.22 (7.37) 69.31 
SLNOSoleno Therapeutics 0.67 10 per month 2.49  0.06  6.31 (4.12) 13.33 
BPTHBio Path Holdings 0.05 9 per month 0.00 (0.09) 6.67 (8.08) 51.22 
MBRXMoleculin Biotech(0.20)9 per month 4.27  0.04  9.75 (7.01) 35.41 
CRNXCrinetics Pharmaceuticals 1.32 9 per month 2.43 (0.01) 3.67 (3.45) 16.75 
ASMBAssembly Biosciences(0.45)8 per month 4.46  0.01  8.49 (5.34) 24.80 
TILInstil Bio(1.77)9 per month 6.84  0.12  20.63 (10.89) 105.83 
CTMXCytomX Therapeutics(0.01)10 per month 0.00 (0.15) 5.00 (5.22) 20.61 
ACHLAchilles Therapeutics PLC(0.03)4 per month 1.53  0.11  3.06 (2.88) 38.16 

Bristol Myers Additional Predictive Modules

Most predictive techniques to examine Bristol price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bristol using various technical indicators. When you analyze Bristol charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bristol Myers Predictive Indicators

The successful prediction of Bristol Myers stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bristol Myers Squibb, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bristol Myers based on analysis of Bristol Myers hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bristol Myers's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bristol Myers's related companies.
 2021 2022 2023 2024 (projected)
Dividend Yield0.03170.03020.04470.0374
Price To Sales Ratio2.993.322.362.98

Story Coverage note for Bristol Myers

The number of cover stories for Bristol Myers depends on current market conditions and Bristol Myers' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bristol Myers is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bristol Myers' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Bristol Myers Short Properties

Bristol Myers' future price predictability will typically decrease when Bristol Myers' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bristol Myers Squibb often depends not only on the future outlook of the potential Bristol Myers' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bristol Myers' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.1 B
Cash And Short Term Investments12.3 B

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.